MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 29.04.2026
Biogen Kurshistorie 2011-2026 | BIIB
Kurshistorie Jährlich Biogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 201 | 133 | 133 | 278 | 211 | 273 | 308 | 328 | 289 | 289 | 259 | 410 | 341 | 166 | 116 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 410 | 116 | 249 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
1.31 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
0.22 | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K |  USA |
 |
Coherus BioSciences
CHRS
|
1.93 | $ 1.59 | -3.64 % | $ 186 M | USA |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | China |
 |
Celldex Therapeutics
CLDX
|
30.7 | $ 31.43 | -0.85 % | $ 2.09 B | USA |
 |
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | France |
 |
BioNTech SE
BNTX
|
91.2 | $ 95.95 | 2.69 % | $ 23.2 B | Germany |
 |
AstraZeneca PLC
AZN
|
74.2 | - | - | $ 96.9 B |  Britain |
 |
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
48.8 | $ 56.18 | -0.35 % | $ 5.05 B |  Schweiz |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
1.31 | - | 0.74 % | $ 768 M |  Israel |
 |
Compugen Ltd.
CGEN
|
2.1 | $ 2.63 | -5.4 % | $ 246 M | Israel |
 |
Abcam plc
ABCM
|
21.6 | - | - | $ 4.9 B | Britain |
 |
Galera Therapeutics
GRTX
|
0.14 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | Britain |
|
Enlivex Therapeutics Ltd.
ENLV
|
0.96 | $ 0.81 | 6.0 % | $ 37 M | Israel |
 |
Affimed N.V.
AFMD
|
4.41 | - | -34.95 % | $ 21.5 M | Germany |
 |
Esperion Therapeutics
ESPR
|
2.7 | $ 3.13 | - | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
20.8 | $ 30.45 | -4.43 % | $ 819 M | USA |
|
Forte Biosciences
FBRX
|
25.9 | $ 19.07 | -8.18 % | $ 247 M | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
2.44 | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
0.47 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
1.7 | - | -7.31 % | $ 87 M | USA |
 |
Galectin Therapeutics
GALT
|
2.79 | $ 2.52 | -1.95 % | $ 161 M | USA |
 |
Generation Bio Co.
GBIO
|
2.77 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
0.82 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | Israel |
 |
Grifols, S.A.
GRFS
|
6.65 | $ 7.85 | -1.63 % | $ 5.34 B |  Spain |
 |
Cyclacel Pharmaceuticals
CYCCP
|
4.9 | - | -4.36 % | $ 27 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
4.4 | - | - | $ 384 M | Britain |
 |
Heron Therapeutics
HRTX
|
1.19 | $ 0.87 | -2.44 % | $ 145 M | USA |
 |
Gracell Biotechnologies
GRCL
|
6.04 | - | - | $ 3.37 B | China |
 |
ImmuCell Corporation
ICCC
|
6.43 | $ 10.24 | 3.43 % | $ 92.4 M | USA |
 |
Anika Therapeutics
ANIK
|
14.9 | $ 14.53 | -2.48 % | $ 208 M | USA |
 |
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.92 | $ 3.35 | -0.3 % | $ 5.51 M | Israel |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | Canada |